Novel Method for Rapid Risk Minimization Evaluation in Electronic Health Data – Assessment of MHRA’s 2012 Label Change for Proton Pump Inhibitors (PPIs)

Aug-17

Database Gastroenterology Musculoskeletal Pharmacoepidemiology

AUTHORS : Dr Rachel E. Sobel, Epidemiology/Worldwide Research and Development, Pfizer Inc, 235 East 42nd St. MS# 219-9-1, New York, NY, 10017, USA – Email: rachel.sobel@pfizer.com

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 26(S2)11-12

DOI : 10.1002/pds.4275

Read more

More publications

Jan-25

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Pharmacoepidemiology

Read more

Jan-25

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Pharmacoepidemiology

Read more

Dec-24

Characteristics and Outcomes of Over a Million Patients with Infammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource

Database

Read more